DIL formerly Duphar-Interfran, has seen one of its promoter increasing its stake in the company by 0.44%. Krishna Datla, one of the Promoter of the company has intimated regarding acquisition of 10,053 (0.44 %) equity shares or 0.44% from the open market in the month of June 2011.
Post acquisition, the holding of Krishna Datla, has gone up from 1,55,765 to 1,65,818 i.e. increase from 06.79% to 07.23% and the holding of DVK Investments, the other promoter, as on date has remained unchanged which is 12,10,528 shares i.e. 52.79%. Also, the total promoters’ holding has now gone up from 13,66,293 shares to 13,76,346 shares i.e. from 59.58% to 60.02%.
DIL is engaged in the business of research support services through its subsidiary Research Support International (RSIL), manufacture and marketing of enzymes and chemicals through its subsidiary Fermenta Biotech (FBL), entertainment through its subsidiary White Stripes Entertainment (WSEL) and manufacture and marketing of levitation technology and wheel chairs through its Joint Venture company, being set up in the Czech Republic.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |